Systems-based hematology is dedicated to improving care delivery for patients with blood disorders. First defined by the American Society of Hematology in 2015, the idea of a systems-based hematologist arose from evolving pressures in the health care system and increasing recognition of opportunities to optimize the quality and cost effectiveness of hematologic care. In this review, we begin with a proposed framework to formalize the discussion of the range of initiatives within systems-based hematology. Classification by 2 criteria, project scope and method of intervention, facilitates comparison between initiatives and supports dialogue for future efforts. Next, we present published examples of successful systems-based initiatives in the field of hematology, including efforts to improve stewardship in the diagnosis and management of complex hematologic disorders (eg, heparin-induced thrombocytopenia and thrombophilias), the development of programs to promote appropriate use of hematologic therapies (eg, blood products, inferior vena cava filters, and anticoagulation), changes in care delivery infrastructure to improve access to hematologic expertise (eg, electronic consultation and disorder-specific care pathways), and others. The range of projects illustrates the broad potential for interventions and highlights different metrics used to quantify improvements in care delivery. We conclude with a discussion about future directions for the field of systems-based hematology, including extension to malignant disorders and the need to define, expand, and support career pathways.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509880PMC
http://dx.doi.org/10.1182/bloodadvances.2020002947DOI Listing

Publication Analysis

Top Keywords

systems-based hematology
16
care delivery
12
hematology including
8
systems-based
6
care
6
hematology
5
hematology highlighting
4
highlighting successes
4
successes steps
4
steps systems-based
4

Similar Publications

Tumor microenvironment-responsive nanoformulations for breast cancer.

Discov Nano

December 2024

School of Health Science and Technology, Dr. Vishwanath Karad MIT World Peace University, S.No. 124, MIT Campus, Paud Road, Kothrud, Pune, 411038, Maharashtra, India.

Nanomedicine, the most promising approach for regulated and targeted drug delivery, is frequently applied in cancer treatment. Essentially, accumulating evidence indicates that nanomedicine has positive results in the treatment of breast cancer (BC), with many BC patients benefiting from nanomedicine-related treatments. Currently, nanodrug delivery systems based on stimulus responses are gaining popularity because of their additional ability to manage drug release depending on the interior environment of the cancer.

View Article and Find Full Text PDF

Objective: Cilostazol is indicated for alleviating intermittent claudication (IC) in stable-phase peripheral arterial disease (PAD) patients. Conducting data mining on adverse events (AEs) of cilostazol in the U.S.

View Article and Find Full Text PDF

Assessing human B cell responses to influenza virus vaccines and adjuvants in a PBMC-derived in vitro culture system.

Vaccine

January 2025

Department of Medical Microbiology & Infection Prevention, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address:

Article Synopsis
  • In vitro systems using human peripheral blood mononuclear cells (PBMCs) can effectively evaluate vaccine responses, particularly focusing on B cells alongside T cells and antigen-presenting cells.
  • The study investigated how B cells in PBMCs respond to different influenza vaccine formulations (whole inactivated virus vs. split virus) and the impact of the adjuvant CpG ODN 2395 on immune responses.
  • Findings revealed that WIV stimulated better B cell differentiation and higher antibody production compared to SIV, with the combination of WIV and CpG leading to the most significant immune responses, highlighting the potential of using PBMCs in early vaccine evaluations.
View Article and Find Full Text PDF

Optimizing quantitative photoacoustic imaging systems: the Bayesian Cramér-Rao bound approach.

Inverse Probl

December 2024

Oden Institute for Computational Engineering and Sciences, The University of Texas, Austin, TX 78712, United States of America.

Quantitative photoacoustic computed tomography (qPACT) is an emerging medical imaging modality that carries the promise of high-contrast, fine-resolution imaging of clinically relevant quantities like hemoglobin concentration and blood-oxygen saturation. However, qPACT image reconstruction is governed by a multiphysics, partial differential equation (PDE) based inverse problem that is highly non-linear and severely ill-posed. Compounding the difficulty of the problem is the lack of established design standards for qPACT imaging systems, as there is currently a proliferation of qPACT system designs for various applications and it is unknown which ones are optimal or how to best modify the systems under various design constraints.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!